Eliquis Kit
NDC Package 0003-3764-74
Package Information
Eliquis (apixaban) kits is eLIQUIS is contraindicated in patients with the following conditions:•Active pathological bleeding [see Warnings and Precautions (5.2) and Adverse Reactions (6.1)]•Severe hypersensitivity reaction to ELIQUIS (e.g., anaphylactic reactions) [see Adverse Reactions (6.1)]. This formulation utilizes a kit delivery system. Marketed by E.r. Squibb & Sons, L.l.c., this product is identified by NDC 0003-3764 and is authorized under FDA application NDA202155.
Identification & Billing
- RxCUI: 1364435 - apixaban 2.5 MG Oral Tablet
- RxCUI: 1364441 - Eliquis 2.5 MG Oral Tablet
- RxCUI: 1364441 - apixaban 2.5 MG Oral Tablet [Eliquis]
- RxCUI: 1364445 - apixaban 5 MG Oral Tablet
- RxCUI: 1364447 - Eliquis 5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0003 - E.r. Squibb & Sons, L.l.c.
- 0003-3764 - Eliquis
- 0003-3764-74 - 1 KIT in 1 CARTON * 32 TABLET, COATED in 1 BLISTER PACK * 42 TABLET, COATED in 1 BLISTER PACK
- 0003-3764 - Eliquis
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0003-3764-74 identifies a specific commercial package of 1 kit in 1 carton * 32 tablet, coated in 1 blister pack * 42 tablet, coated in 1 blister pack of Eliquis 30-day Starter Pack, a human prescription drug labeled by E.r. Squibb & Sons, L.l.c.. This kit is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by E.r. Squibb & Sons, L.l.c. on November 29, 2017. The current certification is valid through December 31, 2027.
How is this E.r. Squibb & Sons, L.l.c. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00003376474. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.